Defigard 400 uses Schiller's patented "multi-pulse biphasic current" technology, which results in lower tissue damage to the patient's heart and facilitates faster recovery. This technology is widely preferred in the advanced markets as it results in lower tissue damage to the patient's heart and facilitates faster recovery.